Tykerb
Drug timelines are a Plus or Pro feature.
72 regulatory and trial events tracked for Tykerb, covering 2007-03-13 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer [NA]